Preschool children with a peanut allergy were able to start eating peanuts after taking part in oral immunotherapy, a new study shows.
The findings confirm and extend previous results that show oral immunotherapy (OIT) can protect children from potentially life-threatening anaphylaxis caused by peanut exposure.
The phase two clinical trial results, published online in the Journal of Allergy and Clinical Immunology, show that one month after completing the OIT protocol, almost 80 percent of trial participants achieved “sustained unresponsiveness,” the highest rate yet reported.
Approximately 3 million people in the United States report having allergies to peanuts and tree nuts.
